Organizing committee invites all participants from all over the world to attend “10th World Congress on Breast Cancer’’ during April 20-21, 2020 in Berlin, Germany.

Breast Cancer is a global overview with the Theme: “Determining The Possible Ways To Cure And Prevent Breast Cancer”   deals with Breast cancer knowledge and characteristics, Screening, Detecting and Diagnosing Breast Cancer, Breast cancer therapy, prevention and medicine, Surgery Choices for Breast Cancer, Personalized Medicine, Clinical trials of Breast Cancer, Male Breast Cancer and Breast cancer Nursing. It is very beneficial for the students, physicians, nurses, doctors, health care people, professors who want to improve their understanding of what will drive and shape the future of the market. It also gives opportunities to the Breast Cancer Societies in Germany to showcase their knowledge and have face to face meetings with scientists increasing their business opportunities. It also gives opportunity to know their market competitors as well as individuals from a wide variety of sector and countries.

Why to attend???

•  Build your professional network.
•  Hear about the latest research.
•  Improve your presentation and communication skills.
•  Get response on an early version of your latest work.
•  Acquire beyond your field or interest.
•  Get opportunity to people to meet you.
•  Know the strengths and weakness of your conferences.
•  Easier to solve the problems and struggles which you go through at work.

Target Audience:

• Scientists
• Young  research  fellows
• Research Scholars
• Residents, Fellows & Post Docs
• Students
• Agro, Bio, Chemical, Medical, Pharma, Technology Companies
• Business Executives & Directors
• Chemistry Associations
• Advertising Agency Executives
• Industry professionals

Market Growth of Breast Cancer:

Breast cancer is a cancer that forms in the cells of the breasts. Breast cancer is the second leading cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Breast cancer is most common after menopause. American Cancer Society, for the year 2016 estimates that about 252,710 new cases of invasive breast cancer will be diagnosed in women, about 63,410 new cases of carcinoma in situ (CIS) will be diagnosed and about 40,601 women will die from breast cancer. The total number of cases registered for five year period 1998-2002 were 13 120 964 (6 848 973 men and 6 271 991 women), the average of annual cases registered to be about 1 250 000 for women and 1 369 795 for men. During this period, 1 775 353 cases of breast cancer were registered worldwide. The highest rates occurred in Europe (Belgium, France, Switzerland, Italy) and in Australia with average rates of 60-100/100 000 cases. The lowest ASR (W) was between 18-30/100 000 in India, Thailand, China and Africa (Harare and Kyadondo).

26,300 women were diagnosed with breast cancer. This represents 25% of all new cancer cases in women in 2017.  5,000 women died from breast cancer. This represents 13% of all cancer deaths in women in 2017.

On average, 72 Canadian women were diagnosed with breast cancer every day. On average, 14 Canadian women died from breast cancer every day. 230 men were diagnosed with breast cancer and 60 died from breast cancer.
 

About 12% of Canadian women (1 in 8) will develop breast cancer over the course of her lifetime. In 2017, an estimated 266,110 new cases of invasive and 63,960 new cases of non-invasive (in situ) breast cancer are expected to be diagnosed.

After increasing incidence rates of breast cancer for the previous two decades, it began decreasing in the year 2000 and dropped by 7% from 2002 to 2003 alone. This decrease was partially due to the reduced use of hormone replacement therapy (HRT) by women after results of a large study called Women’s Health Initiative which was published in the year 2002. These results suggested a relation between HRT and increased breast cancer risk. Though death rates have been decreased since 1989, about 40,610 women are expected to die in the year 2017 in the U.S. from breast cancer. Women under the age of 50 have experienced larger decreases. These decreases are thought to be the result of treatment advances, earlier detection through screening and increased awareness.

Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. In 2017, it is estimated that about 30% of new cases diagnosed in women will be breast cancers.

Breast cancer is more common in African-American women than in white women under the age 45. Overall, African-American women are more likely to die of breast cancer. For Asian, Hispanic and Native-American women, the risk of developing and dying from breast cancer is lower. As many as 40 % cases more cases are predicted by 2030.

Best Regards         
Alex Greenspans | Program Director        
Breast Cancer 2020           
Contact Number: +447480721583
Email: breastcancer@internationalconventions.org
Website: https://breastcancer.conferenceseries.com/